Cargando…
Reversible Left Ventricular Systolic Dysfunction Secondary to Pazopanib
Pazopanib is a tyrosine kinase inhibitor used for the treatment of advanced renal cell carcinoma and advanced soft tissue sarcoma. We describe a case report of a patient with spindle cell sarcoma who developed severe left ventricular systolic dysfunction after starting pazopanib therapy with subsequ...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318145/ https://www.ncbi.nlm.nih.gov/pubmed/30648052 http://dx.doi.org/10.7759/cureus.3517 |